By Donald E. Watenpaugh, PhD Even though CPAP therapy definitively treats obstructive sleep apnea (OSA), adherence remains notoriously poor. That is in part because treating OSA with CPAP therapy often requires attention to much more than just…treating OSA with CPAP therapy. A struggle that is quickly labeled as “CPAP intolerance” is, in most cases, a…
Axsome Therapeutics Inc reported first-quarter corporate updates, noting a 13% year-over-year increase in prescriptions for Sunosi (solriamfetol), used to reduce excessive daytime sleepiness in adults with narcolepsy or sleep apnea. “Based on the performance in the quarter, we are pleased that our marketed products are making a difference in the lives of a growing number…
By Alyx Arnett Dopamine agonists are a popular choice for treating restless legs syndrome (RLS), but an increased understanding that their long-term use can cause augmentation has led some physicians to prescribe other treatments. Characterized by an intense and unpredictable worsening of symptoms, augmentation caused by dopaminergic medications typically occurs six months after beginning therapy…
Oura, the company behind a smart ring that delivers personalized sleep and health data, insights, and daily guidance, announced the acquisition of Proxy, best known for its digital identity signal platform, in an all-equity deal. The acquisition of Proxy’s identification technology, along with its smart ring patent portfolio, will accelerate Oura’s ability to innovate and…
The drug solriamfetol was found to be the most effective treatment for excessive daytime sleepiness (EDS) for people with obstructive sleep apnea (OSA), according to a study comparing the efficacy and safety of wakefulness-promoting agents published in the Annals of Internal Medicine. The standard treatment for OSA is a positive airway pressure (PAP) mask that…
Vivos Therapeutics Inc, which makes oral appliances for treating breathing-related sleep disorders, has implemented initiatives to improve operational efficiencies, reduce expenses, and take advantage of growth opportunities. These initiatives touch most aspects of the company’s operations and include expense reductions, product suite expansion, and organizational changes that included an approximate 17% reduction of its workforce.…
ABSTRACT: The majority of surviving Greek manuscripts include Mark 16:9–20 at the end of the Gospel, and the majority of Christians throughout church history have received these verses as God’s word. Nevertheless, both external and internal evidence suggest that Mark likely ended his Gospel at verse 8, however abrupt the conclusion may seem. Externally, the…
MCRA LLC, a medical device-focused regulatory advisory firm and clinical research organization, assisted Noctrix Health in obtaining marketing authorization via a De Novo Request from the US Food and Drug Administration (FDA) for the NTX100 Tonic Motor Activation (NTX100 TOMAC) System for patients with restless legs syndrome. The device is indicated to reduce symptoms of…